TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
106,508
|
101,205
|
70,375 |
Financial expenses |
0
|
1
|
4 |
Earnings before taxes |
12,184
|
14,637
|
10,247 |
EBITDA |
11,040
|
13,622
|
6,870 |
Total assets |
47,637
|
45,902
|
29,893 |
Current assets |
39,838
|
41,128
|
25,084 |
Current liabilities |
11,141
|
15,723
|
8,984 |
Equity capital |
34,359
|
28,612
|
19,562 |
- share capital |
101
![]() |
101
|
100 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
62.3%
|
65.4% |
Turnover per employee |
8,193
|
7,785
|
5,865 |
Profit as a percentage of turnover |
11.4%
|
14.5%
|
14.6% |
Return on assets (ROA) |
25.6%
|
31.9%
|
34.3% |
Current ratio |
357.6%
|
261.6%
|
279.2% |
Return on equity (ROE) |
35.5%
|
51.2%
|
52.4% |
Change turnover |
5,303
|
30,830
|
14,815 |
Change turnover % |
5%
|
44%
|
27% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.